Mark Anthony Levstik

Mark Levstik practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Mark Levstik's NPI, 1639628068, was assigned on September 27, 2016. Mark Levstik graduated from Royal College of Surgeons Ireland in 1990. Mark Levstik holds New York license 286703.

Mark Levstik's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Mark Levstik's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. Mark Levstik is also affiliated with Highland Hospital. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Mark Levstik to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Levstik practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Mark Levstik's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Mark Levstik is licensed in New York.

CMS data shows 103 Medicare services from Mark Levstik across 2 procedure codes in 2024, for 83 Medicare patients. Medicare paid $8,589 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 83 Medicare patients who saw Mark Levstik in 2024. The largest group is 65 to 74, with 39 patients. 75% of them have high blood pressure, and 60% have high cholesterol. 41% are also on Medicaid. Their average risk score is 2.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Levstik's median patient age at 63, with 54% women.

In 2024, Mark Levstik wrote 75 Medicare Part D claims for 23 patients. 75% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $44,007 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Mark Levstik for performance year 2024, reported as part of a group. Mark Levstik accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Levstik as offering telehealth. CMS counts 67 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Mark Levstik, more than 69% of the clinicians it reports for that procedure.

CMS Open Payments shows 9 general payments to Mark Levstik from 4 drug and device companies from 2017 to 2019. Consulting fees make up the largest share, 91% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $1,100.

Mark Levstik graduated from Royal College of Surgeons Ireland in 1990.